June 08th, 2023

REV Group, Inc. (NYSE: REVG) has announced its second-quarter fiscal 2023 results, with adjusted earnings per share (EPS) of $0.35, surpassing the consensus estimate of $0.18.  Additionally, the company has raised its full-year fiscal 2023 ne. Read more

June 08th, 2023

Chindata Group Holdings Limited (Nasdaq: CD) has announced the formation of a special committee to review a non-binding proposal from BCPE Bridge Cayman, L.P. and BCPE Stack Holdings, L.P.  The proposal suggests acquiring all outstanding ordi. Read more

June 08th, 2023

Innate Pharma (Nasdaq: IPHA) shared important news from Sanofi (Nasdaq: SNY) regarding the U.S. Food and Drug Administration (FDA) granting Fast Track Designation for SAR'579 / IPH6101 to treat hematological malignancies.  The FDA's Fast Trac. Read more

June 08th, 2023

Semtech Corporation (Nasdaq: SMTC) has delivered better-than-expected results in the first quarter of fiscal 2024, reporting earnings per share (EPS) of $0.02, surpassing the consensus estimate of a loss of $0.08 per share.  Looking ahead to . Read more

June 07th, 2023

Trip.com Group Limited (Nasdaq: TCOM) delivered a strong performance in the first quarter of 2023, easily surpassing the consensus estimate of $0.25 with an adjusted EPS of $0.45.  The company's net revenue experienced an impressive 124% year. Read more

June 07th, 2023

Torrid Holdings Inc. (NYSE: CURV) reported first-quarter fiscal 2023 earnings per share (EPS) of $0.11, slightly lower than the consensus estimate of $0.12.  Looking ahead, the company projects net sales for the second quarter of fiscal 2023 . Read more

June 07th, 2023

Farmer Brothers Company (Nasdaq: FARM) has entered into an agreement to sell its direct ship business and facility to TreeHouse Foods, Inc. for approximately $100 million - subject to customary purchase price adjustments -, allowing Farmer Brothers t. Read more

June 07th, 2023

FibroGen, Inc. (Nasdaq: FGEN) announced the topline data from the Phase 3 LELANTOS-1 trial, evaluating pamrevlumab as a treatment for non-ambulatory patients with Duchenne Muscular Dystrophy (DMD) on background corticosteroids.  Unfortunately. Read more

June 07th, 2023

Casey's General Stores, Inc. (Nasdaq: CASY) announced its financial results for the fourth quarter of fiscal year 2023. The company reported earnings per share (EPS) of $1.49, which fell short of the consensus estimate of $1.59.  Following th. Read more

June 07th, 2023

  FOR IMMEDIATE RELEASE 2023-103 Washington D.C. / CRWE PRESS RELEASE / June 6, 2023  — The Securities and Exchange Commission today filed an emergency action application seeking a temporary restraining order freezing assets, d. Read more